Bevacizumab for recurrent primary central nervous system lymphoma: A new treatment?

Karina Nieto, Leo I. Gordon, Jeffrey Raizer*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1648-1649
Number of pages2
JournalNeuro-oncology
Volume17
Issue number12
DOIs
StatePublished - 2015

Keywords

  • Bevacizumab
  • PCNSL

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this